Fig. 4From: Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literatureContrast-enhanced abdominal CT scan after switching to alectinib. Panels A-D: Two months after switching the therapy to alectinib, showing no recurrence or enlargement of cystic lesions in the kidneys and liverBack to article page